Streetbeat News

Products Services

CYBN

Cybin Inc. has announced the completion of Phase 2 Cohort 5 dosing of CYB003 in Major Depressive Disorder. This marks a significant milestone in the development of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:57 am

AAPL

HNHPF

SSNLF

TSM

XIACY

Apple Inc's stock is trading higher amid reports that it has urged suppliers to produce about 85 million units of the iPhone 15 in 2023, which is roughly in line with 2022. The company is considering raising the price for Pro models, which could increase overall revenue. Despite minor issues with new iPhone screens and a production challenge with CMOS image sensors, the company's market capitalization has reached $3 trillion. Apple's sales slid 2% in the most recent quarter, but its market share rose to 17% due to growth in demand for premium phones.

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 11:56 am

GOOG

GOOGL

META

Meta Platforms Inc's messaging service, Instagram Threads, has attracted influencers due to its welcoming atmosphere and creative freedom. However, the platform lacks essential features for creators to expand their audiences and monetize their presence. Influencers are cautious about the app's potential impact on their careers and prioritize established platforms like Alphabet Inc's YouTube. Meta plans to prioritize building consumer value before exploring business value, but faces the challenge of finding sustainable momentum for Threads in the long term.

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 11:53 am

ETHUSD

SOL

SOLUSD

Former First Lady Melania Trump has launched a new collection of non-fungible tokens (NFTs) featuring a photograph of NASA astronaut Buzz Aldrin's moonwalk, which reportedly breaches NASA's policies that prohibit the use of its imagery in NFTs. The NFT collection, titled 'Man on the Moon', was unveiled on the 54th anniversary of the Apollo 11 mission. Melania Trump has been actively involved in the NFT space, introducing a range of NFTs that celebrate significant moments in American history.

Portfolio Pulse from Mehab Qureshi

July 24, 2023 | 11:50 am

NVDA

TSM

Nvidia Corp's stock traded higher amid reports of a potential sales rebound for supplier Taiwan Semiconductor Manufacturing Company Ltd (TSMC) in 2024. Despite a slump in consumer electronics demand, strong demand for AI chips from Nvidia and peers is expected to trigger the rebound. Additionally, discussions over easing China's semiconductor policy could unlock additional value for Nvidia.

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 11:46 am

VRSSF

VERSES AI Inc (OTC:VRSSF) has collaborated with Dentons US and the Spatial Web Foundation to release a landmark AI industry report, 'The Future of Global AI Governance'. The report proposes an International Rating System for Autonomous Intelligent Systems (AIRS) to address potential regulatory blind spots. The report's goal is to provide a pragmatic framework for future policymaking and compliance. The research also points to the development of socio-technical standards by the Institute of Electrical and Electronics Engineers (IEEE).

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 11:45 am

ANIX

EFSH

VIRC

Insiders at Virco Mfg. Corporation (VIRC), Anixa Biosciences, Inc. (ANIX), and 1847 Holdings LLC (EFSH) have recently made notable purchases of their companies' stocks. Virco's director bought 1,770 shares after the company posted a narrower-than-expected Q1 loss. Anixa's President, COO, and CFO acquired 5,500 shares following the issuance of a Canadian Patent for its CAR-T cancer therapy technology. A 10% owner of 1847 Holdings bought 72,327 shares as the company anticipates a 54% YoY increase in Q2 revenue.

Portfolio Pulse from Lisa Levin

July 24, 2023 | 11:43 am

SLGC

SomaLogic has partnered with Dante Genomics to promote the adoption of proteomics in clinical research across Europe. The partnership aims to leverage SomaLogic's SomaScan platform to provide proteomic data for Dante's genomic services.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:32 am

ADCT

Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals and ADC Therapeutics SA (NYSE:ADCT), announced that the China National Medical Products Administration (NMPA) has accepted the Biologics License Application (BLA) for ZYNLONTA, a treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in China. The BLA has been granted priority review by the NMPA.

Portfolio Pulse from Charles Gross

July 24, 2023 | 11:26 am

TNGX

Tango Therapeutics has announced the dosing of the first patient in the Phase 1/2 trial of TNG260 in combination with Pembrolizumab for STK11-mutant cancers. This marks a significant step in the development of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:14 am